Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings
  4. ESMO Congress 2024
  5. Satellite Symposia Webcasts

Astellas - Guiding the future of mG/GEJ adenocarcinoma: Emerging biomarkers in the evolving treatment paradigm

A look ahead into the practicalities of an evolving treatment paradigm

Date

13 Sep 2024

Session

Astellas - Guiding the future of mG/GEJ adenocarcinoma: Emerging biomarkers in the evolving treatment paradigm

Topics

Tumour Site

Gastric Cancer;  Gastro-Oesophageal Junction Cancer

Presenters

Nicola Fazio

Authors

N. Fazio

Author affiliations

  • Gastrointestinal Medical Oncology And Neuroendocrine Tumors, IEO - Istituto Europeo di Oncologia IRCCS, 20141 - Milan/IT

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and introduction

Presenter: Javier Sastre Varela

Session: Astellas - Guiding the future of mG/GEJ adenocarcinoma: Emerging biomarkers in the evolving treatment paradigm

Resources:

Webcast

Preparing for smooth sailing: panel discussion and Q&A

Presenter: Javier Sastre Varela, Frederique Penault-Llorca, Nicola Fazio

Session: Astellas - Guiding the future of mG/GEJ adenocarcinoma: Emerging biomarkers in the evolving treatment paradigm

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.